Sandoz Group AG

Sandoz Group AG, a division of the global healthcare giant Novartis, is a leader in the production of generic pharmaceuticals and biosimilars. It is recognized for providing access to high-quality, affordable medicines worldwide. The company's primary function is to manufacture and distribute generic drugs, focusing on affordability and availability, which plays a crucial role in enhancing healthcare accessibility, particularly in cost-sensitive markets. With a diverse product portfolio that spans therapeutic areas including oncology, antibiotics, and central nervous system medications, Sandoz impacts various critical sectors of the pharmaceutical industry. Sandoz is integral to addressing the challenges of growing healthcare costs by offering alternatives to costly branded medications. The company's dedication to research and development in biosimilars underscores its commitment to innovation and fostering competition in the biopharmaceutical sphere. Based in Switzerland, Sandoz’s strategic initiatives contribute significantly to its stature as a cornerstone in the global generics market, supporting health systems and easing economic pressures by ensuring that essential medications remain economically feasible while maintaining high standards of quality and efficacy.